Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Sandeep Jauhar, MD, cardiologist and author, describes, via his office webcam, the experience of being an intern and the subject of his book, Intern: A Doctor’s Initiation, a…
NEW YORK (Reuters Health) – Among women undergoing resection of endometrial polyps, the prevalence of malignant or premalignant polyps ranges from about 2% to 5%, with the higher…
NEW YORK (Reuters Health) – A multifaceted program aimed at increasing compliance with preventive measures leads to a sustained reduction in the rate of ventilator-associated pneumonia (VAP), a…
NEW YORK (Reuters Health) – For patients with rheumatoid arthritis (RA), treatment with anti-tumor necrosis factor (TNF) agents appears to reduce their risk of cardiovascular events, including MI…
NEW YORK (Reuters Health) – A population-based study from Scotland shows that fewer than one in every 100 patients with subclinical hyperthyroidism will progress to overt hyperthyroidism. In…
NEW YORK (Reuters Health) – Postmenopausal women treated for osteoporosis with the selective estrogen receptor modulator lasofoxifene have a reduced risk of coronary heart disease events, researchers report…
NEW YORK (Reuters Health) – Among low-risk patients undergoing elective percutaneous coronary intervention, 1-year outcomes are worse if their antiplatelet response to clopidogrel is low, an Italian team…
NEW YORK (Reuters Health) – The hope of finding a way to quickly measure carboxyhemoglobin levels in suspected carbon monoxide poisoning is still unfulfilled, it seems. The Rad-57…
NEW YORK (Reuters Health) – In patients being treated for acute coronary syndromes (ACS), the loading dose of ticagrelor has a stronger inhibitory effect on platelets than does…
NEW YORK (Reuters Health) – The evaluation of pigmented lesions for early detection of melanoma is aided by the use of MelaFind, a non-invasive automated vision-computer system, according…
